Pyramid Pharma Services Expands Product Line with 13th Therapy for Rare Blood Cancers

Pyramid Pharma Services Expands Product Line

Pyramid Pharma Services has taken a significant step forward in its growth journey by announcing the addition of its 13th commercial product. This expansion comes through an enhanced partnership with a long-standing biopharmaceutical client, focusing on a therapy that has received approval for treating rare blood cancers. The introduction of this new cartridge-based program illustrates Pyramid’s commitment to adapting and evolving with the needs of its customers and the ever-changing pharmaceutical landscape.

Investment in Advanced Manufacturing

This development is underpinned by recent investments in Pyramid's facility located in Costa Mesa, California. The company has integrated a high-speed Groninger aseptic fill-finish line, which is pivotal for ensuring quality and efficiency not only in filling vials and prefilled syringes but also in the newly introduced cartridge format. Furthermore, the incorporation of automated device assembly capabilities via the Mikron platform enhances the organization's capacity to produce complex injectable products.

Dirk Lange, the CEO of Pyramid Pharma Services, emphasized the significance of these advancements, stating that they reflect the firm’s dedication to forging long-term partnerships with clients. He noted that as biopharmaceutical products progress from conception to commercial launch, their manufacturers’ needs evolve, and hence, Pyramid must remain proactive in investing strategically in its capabilities and expertise.

Comprehensive Service Offering

The new aseptic fill-finish and automated device assembly capabilities enable Pyramid to offer a more integrated solution for pharmaceutical and biotech clients. This is particularly important as the industry shifts toward more sophisticated drug delivery systems. The Groninger line not only streamlines the filling process but also incorporates quality checks that align with industry standards, reassuring clients regarding the reliability of their products.

Additionally, by combining filling, assembly, labeling, and packaging processes on one site, Pyramid creates a seamless pathway from sterile drug product filling to device assembly and final packaging. This holistic approach serves to mitigate risks and improve turnaround times, which are critical factors in the pharmaceutical industry.

Track Record and Future Endeavors

Pyramid Pharma Services boasts a rich history of over 38 years in the contract development and manufacturing domain, marked by numerous successful FDA inspections. This proven track record establishes the company as a reliable partner in the realm of sterile injectable drugs, supporting over a dozen commercial products while numerous additional programs are currently advancing toward performance qualification.

With an unwavering commitment to quality supply, Pyramid is well-positioned to cater to the comprehensive needs of its partners, thus reinforcing its status as a leader among CDMOs. As they continue to support clients through each stage of development and commercialization, their promise remains focused on innovation, dependability, and strategic growth.

About Pyramid Pharma Services

Headquartered in Costa Mesa, California, Pyramid Pharma Services specializes in contract development and manufacturing for sterile injectable drug products. Their array of capabilities spans formulation development, aseptic fill-finish, lyophilization, and device assembly, ensuring comprehensive support for pharmaceutical and biotechnology companies from initial clinical trials to commercial supply. With over two decades of expertise in the field, Pyramid aims to deliver excellence in every aspect of its operation, fostering successful collaborations in the industry. For further information about their services, visit Pyramid Pharma Services.